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Class IIa histone deacetylases (HDACs) -4, -5, -7 and -9 undergo signal-dependent nuclear export
upon phosphorylation of conserved serine residues that are targets for 14-3-3 binding. Little is
known of other mechanisms for regulating the subcellular distribution of class IIa HDACs. Using a
biochemical puriﬁcation strategy, we identiﬁed protein kinase C-related kinase-2 (PRK2) as an
HDAC5-interacting protein. PRK2 and the related kinase, PRK1, phosphorylate HDAC5 at a threonine
residue (Thr-292) positioned within the nuclear localization signal (NLS) of the protein. HDAC7 and
HDAC9 contain analogous sites that are phosphorylated by PRK, while HDAC4 harbors a non-phos-
phorylatable alanine residue at this position. We provide evidence to suggest that the unique phos-
pho-acceptor cooperates with the 14-3-3 target sites to impair HDAC nuclear import.
Structured summary:
MINT-7710106:HDAC5 (uniprotkb:Q9UQL6) physically interacts (MI:0915) with PRK2 (uniprotkb:Q16513)
by pull down (MI:0096)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Chromatin structure can be altered by post-translational modi-
ﬁcation of e-amino groups of multiple conserved lysine residues
within nucleosomal histone tails [1]. Histone acetyltransferase-
mediated transfer of acetyl groups from acetyl coenzyme A to
nucleosomal lysines results in charge neutralization of the amino
acid, which weakens the interaction of positively charged histone
tails with the negatively charged phosphate backbone of DNA,
and culminates in chromatin relaxation. Histone deacetylases
(HDACs) catalyze removal of acetyl-groups from lysines. HAT and
HDAC activity is generally associated with gene activation and
gene repression, respectively.
The 18 mammalian HDACs are grouped into four classes on the
basis of similarity to yeast transcriptional repressors [2]. Class I
HDACs (1, 2, 3 and 8) are related to yeast RPD3, class II HDACs
(4, 5, 6, 7, 9 and 10) to yeast HDA1, and class III HDACs (SirT
1–7) to yeast Sir2. Class II HDACs are further divided into twochemical Societies. Published by E
ology, University of Colorado
14 A, Aurora, CO, USA.
T.A. McKinsey).subclasses, IIa (HDACs 4, 5, 7 and 9) and IIb (HDACs 6 and 10).
HDAC11 falls into a fourth class [3].
Class IIa HDACs regulate genes involved in a variety of processes,
including skeletal muscle differentiation, cardiac hypertrophy as
well as neuron and lymphocyte apoptosis. Derepression of class
IIa HDAC target genes is accomplished, in part, by signal-dependent
phosphorylation of the HDACs at regulatory serine residues that
serve as docking sites for the 14-3-3 intracellular chaperone protein
[4–6]. These sites are not present in class I, IIb, III or IV HDACs. Phos-
phorylation-dependent binding of 14-3-3 to class IIa HDACs results
in redistribution of HDACs to the cytoplasm. The mechanism for
this redistribution involves activation of a CRM1 exportin-depen-
dent nuclear export sequence (NES) in the HDACs and masking of
an HDAC nuclear localization signal (NLS) [4,7–9]. Several kinases
have been shown to phosphorylate the 14-3-3 target serines in
class IIa HDACs [10], including protein kinase D (PKD) [11] and cal-
cium/calmodulin-dependent protein kinase (CaMK) [12].
Alternative mechanisms for regulating class IIa HDAC subcellu-
lar localization have been described. Extracellular signal-regulated
kinase was shown to associate with HDAC4 and stimulate its nu-
clear import, although the relevant phospho-acceptor sites were
not deﬁned [13]. Additionally, phosphorylation of a serine residuelsevier B.V. All rights reserved.
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port [14], and Dyrk-1B was shown to impair class IIa HDAC nuclear
import through phosphorylation of a conserved site within the NLS
of the HDACs [15]. Oxidation of cysteine residues in HDAC4 has
also been linked to phosphorylation-independent nuclear export
of this class IIa HDAC [16].
To further deﬁne mechanisms for regulating class IIa HDACs, we
used human heart explants to identify proteins capable of interact-
ing with a GST-HDAC5 fusion protein matrix. Here, we describe an
interaction between protein kinase C-related kinases (PRKs) and
HDAC5. A novel phosphorylation site was mapped to the NLS of
HDAC5. This site is conserved in HDAC7 and HDAC9, but is absent
from HDAC4. The data suggest that phosphorylation of this site im-
pairs nuclear import of HDACs.2. Methods
2.1. Biochemical puriﬁcation of HDAC5-associated proteins
Human heart explants from patients with idiopathic dilated car-
diomyopathy (20 g total left ventricular tissue) were homoge-
nized in Tris buffer (50 mM; pH 7.5) containing EDTA (1 mM),
NaCl (100 mM), and protease inhibitors. Insoluble debris was pel-
leted by centrifugation. Soluble proteins were precipitated by
sequential exposure to 20%, 40%, and 60% ammonium sulfate on
ice for 20 min. After centrifugation, precipitated proteins were
resuspended in homogenization buffer and assayed for HDAC5-di-
rected kinase activity, as described below. Protein present in the
60% ammonium sulfate precipitate was fractionated employing
POROS anion exchange resin and a BioCAD perfusion chromatogra-
phyworkstation. Proteins were bound to the resin in Tris buffer (pH
7.5) containing 50 mM NaCl and eluted with an increasing linear
gradient of NaCl. Fractions 19 and 20, which contained the bulk of
the HDAC5-directed activity (data not shown), were pooled and
sequentially added to the GST and GST-HDAC5 afﬁnity resins. Re-
sin-bound proteins were eluted with Tris buffer (50 mM; pH 7.4)
containing NaCl (0.5 M). Proteins were precipitated using chloro-
form/methanol solution, resolved by SDS–PAGE, and stained with
colloidal Coomassie Brilliant Blue dye. Proteins found in association
with GST-HDAC5 but not GST alone were excised from the gel,
dried, and rehydrated in sequencing grade trypsin (Promega) for
20 min on ice prior to overnight incubation at 37 C. As a negative
control, the analogous region of the gel from the GST only lane
was excised and analyzed in parallel. Tryptic peptides were ex-
tracted in 0.1% triﬂuoroacetic acid concentrated, bound to C18 resin,
washed in 0.1% TFA, and eluted from the resin with 80% acetonitrile
in 0.1% TFA. Eluted peptides were mixed with a matrix of a-cyano-
4-hydroxy-cinnamic acid on a Matrix Assisted Laser Desorption
Ionization-Time Of Flight (MALDI-TOF) plate and peptide mass
spectra were acquired using a MALDI-TOF mass spectrometer in
the reﬂector mode. Spectra were calibrated with autolytic products
of trypsin and mono-isotopic peptide masses were used to search
the National Center for Biotechnology Information database. A
truncated form of protein kinase C-related kinase-2 (PRK2) was
found in association with GST-HDAC5, but not GST alone.
2.2. Cell culture and DNA transfection
COS cells were grown in Dulbecco’s modiﬁed Eagle’s medium
containing 10% fetal bovine serum (10%), L-glutamine (2 mM),
and penicillin–streptomycin. For transfection, cells were plated
on six-well dishes (5  105 cells/well) 1 day prior to transfection
with the lipid-based reagent Fugene 6 (Roche). A truncated active
form of PRK1 (amino acids 511–942) and the analogous truncation
of PRK2 were constructed by PCR with PFU Turbo (Stratagene) andcloned into pcDNA3.1+, based on the work of Ono et al. [17]. Inac-
tive PRK1 contains a glutamic acid substitution in place of the cat-
alytic lysine at position 644.
2.3. In vitro phosphorylation assay with GST-HDAC5 substrates
GST-HDAC5 substrate containing amino acids 218–328 of
HDAC5 fused to the carboxy-terminus of GST was generated in
the BL21 strain of E. coli employing the pGEX-KG bacterial expres-
sion vector. Internal deletion mutants of HDAC5 were generated by
PCR with PFU Turbo polymerase (Stratagene). GST-HDAC5 protein
(1 lg) was conjugated to glutathione-agarose beads (Amersham)
and beads were washed extensively with PBS prior to use in
in vitro kinase reactions. For analysis of kinase activity in column
fractions, 1% of each fraction was mixed (2 h, 4 C, rocking) with
GST-HDAC5 beads in 500 ll PBS containing EDTA (1 mM), Triton X-
100 (0.1%), PMSF (1 mM) and protease inhibitor cocktail (Roche).
Beads were washed twice in with the same buffer and equilibrated
with kinase reaction buffer [HEPES (25 mM; pH 7.6) MgCl2
(10 mM), and CaCl2 (0.1 mM). Beads were resuspended in kinase
reaction buffer (30 ll) containing 12.5 lM ATP and 5 lCi [c-32P]-
ATP and reactions were allowed to proceed for 30 min at room
temperature. Reactions were boiled, and phospho-proteins re-
solved by SDS–PAGE and visualized by autoradiography. For exper-
iments with recombinant kinases, COS cells were transfected with
mammalian expression vectors for constitutively active forms of
PRK1, PRK2 or PKC theta or a catalytically inactive form of PRK1
(1 lg each). Forty-eight hours following transfection, protein ly-
sates were prepared in PBS containing Triton-X100 (0.5%), EDTA
(1 mM), PMSF (1 mM), and protease inhibitor cocktail (Roche). Ly-
sates were sonicated brieﬂy and clariﬁed by centrifugation. GST-
HDAC5 beads were mixed with 20 lg total COS lysate and kinase
reactions performed as described above.
2.4. Kinase assays with peptide substrates
Kinase activity was measured using a biotinylated HDAC5
peptide (Arg-Arg-Lys-Asp-Gly-Thr-Val-Ile-Ser291-Thr-Phe-Lys-Lys-
Arg) or the corresponding peptides from HDAC4 (Arg-Arg-Lys-
Asp-Gly-Pro-Val-Val-Thr-Ala-Leu-Lys-Lys-Arg), HDAC7 (Arg-Lys-
Glu-Ser-Ala-Pro-Pro-Ser-Leu-Arg-Arg-Arg) or HDAC9 (Arg-Arg-
Lys-Asp-Gly-Asn-Val-Val-Thr-Ser-Phe-Lys-Lys-Arg) and 96-well
streptavidin-coated plates (Promega) and a vacuum system, as
previously described [18]. Standard reaction mixtures contained
biotinylated peptide (0–40 lM), 50 lM [c-32P] ATP (1  105
cpm), DTT (1 mM), MgCl2 (10 mM), Hepes buffer (50 mM; pH
7.6) and enzyme solution (0.1 lg) in a ﬁnal volume of 50 ll. After
incubation at 25 C for 30 min, 10 ll of the reaction mixture was
withdrawn and added to streptavidin-coated 96-well plates.
Wells were washed successively with 1.2 ml of NaCl (2 M),
1.2 ml of NaCl containing 1% H3PO4, 600 ll H2O and 200 ll 95%
ethanol. Plates were allowed to dry in a hood at 25 C for 1 h
and then 25 ll of scintillation ﬂuid (Microscint 20) was added
to each well. Incorporation of [c-32P] ATP into peptide substrates
was measured using a Top-Count NXT (Packard). Recombinant
PRK1 and PRK2 were purchased from Invitrogen. SAMTM 96-well
biotin capture plates were obtained from Promega. ATP and DTT
were obtained from Sigma Chemicals. Peptides were purchased
from American Peptide Company. [c-32P] ATP (6000 Ci/mmol)
was purchased from Perkin–Elmer.
2.5. GFP-MITR localization studies
Full-length MEF2-interacting transcription repressor (MITR)
was fused in-frame to green ﬂuorescent protein (GFP) in the pEG-
FP-C1 expression plasmid (Clontech). Site-directed mutants were
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cells were grown on six-well plates as described above and trans-
fected with expression vectors for GFP-MITR (0.5 lg) and activated
CaMKI (1.0 lg). After overnight incubation, cells were treated with
leptomycin B (LMB; 20 nM) for 2 h, as indicated, and cells were
washed three times with PBS and covered with mounting solution
(Molecular Probes, SlowFade) and glass coverslips. GFP-MITR was
visualized with an inverted ﬂuorescence microscope (Olympus,
BH-2) at 40 magniﬁcation and images captured using a digital
camera (Roper Scientiﬁc, Photometrics).
3. Results
3.1. Identiﬁcation of PRK2 as an HDAC5-associated kinase
HDAC5 domain structure is shown in Fig. 1A. HDAC5 contains
an amino-terminal NLS that is ﬂanked by two phospho-acceptor
serine residues (S-259 and S-498) that, upon phosphorylation,
are targets for the 14-3-3 chaperone protein. Binding of 14-3-3
to HDAC5 activates a cryptic, carboxy-terminal NES that is a target
for the CRM1 nuclear export receptor. Like other class IIa HDACs,
HDAC5 contains a conserved deacetylase domain that exhibits
minimal catalytic activity toward canonical substrates.Fig. 1. Identiﬁcation of PRK2 as an HDAC5-associated protein. (A) HDAC5 contains a nuc
14-3-3 chaperone protein upon phosphorylation. HDAC5 contains a nuclear export sequ
binding. The solid phase HDAC5 kinase assay employed a GST-HDAC5 substrate conjuga
amino acids 218–328, containing the regulatory serine at position 259. (B) Failing adult h
Soluble proteins were precipitated by sequential exposure to 20%, 40% and 60% ammoniu
GST-HDAC5 and [c-32P-ATP]. Proteins were resolved by SDS–PAGE, stained with Cooma
depiction of the puriﬁcation strategy that identiﬁed PRK2 in association of GST-HDAC5.As an initial step toward deﬁning novel mechanisms for regu-
lating HDAC5, a portion of HDAC5 containing the NLS and ﬂanking
amino acids was fused in-frame to glutathione-S-transferase (GST)
and used as a substrate in in vitro kinase assays. The substrate is
depicted in Fig. 1A. Soluble protein was prepared from failing hu-
man heart explants and incorporated into kinase assays with 32P-
ATP and the GST-HDAC5 substrate. As shown in Fig. 1B (lane 1),
the substrate was efﬁciently phosphorylated by a cardiac kinase(s).
The bulk of the phosphorylation was directed toward the 14-3-3
target site at Ser-259, as indicated using a GST-HDAC5 substrate
containing non-phosphorylatable alanine at position 259
(GST-HDAC5 [S259A]; lane 2). However, phosphorylation of the
serine-to-alanine substrate was still detectable, albeit at a mark-
edly reduced level (lane 2), suggesting the presence of a novel
phospho-acceptor site within this region of HDAC5. Crude heart
lysate was fractionated by ammonium sulfate precipitation in an
attempt to enrich for the kinase(s) that phosphorylates the novel
site. As shown in Fig. 1B, 60% ammonium sulfate precipitation dra-
matically enriched for an activity capable of phosphorylating the
GST-HDAC5 (S259A) substrate (compare lanes 2, 4 and 6).
The column chromatography scheme shown in Fig. 1C was em-
ployed to purify the kinase responsible for phosphorylating the
GST-HDAC5 substrate at a site other than Ser-259, as detailed inlear localization sequence (NLS) that is ﬂanked by two serines that are bound by the
ence (NES) that is engaged by the CRM1 nuclear export receptor following 14-3-3
ted to glutathione–agarose beads. The region of HDAC5 fused to GST encompasses
uman heart was homogenized, and insoluble debris was pelleted by centrifugation.
m sulfate. Precipitates were resuspended and incorporated into kinase assays with
ssie blue dye and 32P-labeled HDAC5 detected by autoradiography. (C) Schematic
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no acids 650–948), a ubiquitous serine/threonine kinase.
3.2. PRK1 and PRK2 phosphorylate HDAC5
In vitro kinase assays were performed to determine if PRK2 and
the related kinase, PRK1, are indeed capable of phosphorylating
HDAC5. Whole-cell protein lysates were prepared from mock
transfected COS cells or COS cells overexpressing active forms of
PRK1, PRK2 or PKCh or an inactive form of PRK1 and incorporated
into in vitro kinase reactions with GST-HDAC5 substrate. As shown
in Fig. 2A, ectopic PRK1 and PRK2 efﬁciently phosphorylated the
GST-HDAC5 substrate (lanes 2 and 4). In contrast, no signiﬁcant
phosphorylation of the substrate was detected when using protein
from mock transfected cells or from cells overexpressing catalyti-
cally inactive PRK1 (kinase-dead [KD]) or active PKCh, illustrating
the selectivity of the effect of PRK on the HDAC5 substrate. As
shown in Fig. 2B, PRK2 also efﬁciently phosphorylated the GST-
HDAC5 (S259A) substrate (lane 3), which is consistent with the no-
tion that PRK2 is, at least in part, responsible for phosphorylating
the novel site in HDAC5.
3.3. Mapping the PRK target site on HDAC5
A series of GST-HDAC5 deletion constructs was prepared to be-
gin to map the site(s) on HDAC5 that are phosphorylated by PRK
(Fig. 3A). All of these experiments employed lysate from COS cells
overexpressing active PRK2. Initial mapping studies indicated that
PRK targets sequences between amino acids 277 and 328 in HDAC5
(Fig. 3B, compare lanes 2 and 4). Further deletions revealed a phos-
phorylation site(s) between amino acids 285 and 300 (Fig. 3C),
which are found in the distal region of the HDAC5 NLS. Primary
amino acid analysis of the PRK target region of HDAC5 revealed
three possible phospho-acceptors, Thr-288, Ser-291 and Thr-292
(Fig. 4A).
Kinetic studies were performed with synthetic peptide sub-
strates to further deﬁne the interplay between PRK and HDAC5. Re-
combinant PRK1 and PRK2 efﬁciently phosphorylated a 14 aminoFig. 2. Recombinant PRK1 and PRK2 phosphorylate GST-HDAC5 at a unique site. (A) COS
constitutively active PRK1 (lane 2), catalytically inactive PRK1 (lane 3), PRK2 (lane 4), or P
incorporated into in vitro kinase assays using GST-HDAC5 substrate. Proteins were resolv
detected by autoradiography (top panel). Equivalent substrate input was demonstrate
overexpressing PRK2 were used in kinase assays with GST alone (lane 1), GST-HDAC5 (lan
serine 259 (GST-HDAC5 [S259A]; lane 3).acid peptide based on amino acids 281–296 of HDAC5, with Km
for peptide of 20.60 ± 0.66 lM and 15.83 ± 1.69 lM, respectively
(Fig. 4B and C). Use of peptides containing alanine in place of
Ser-291 and/or Thr-292 revealed that Thr-292 is the primary site
on the peptide that is targeted by PRK (Fig. 4D). Consistent with
this, peptides based on HDAC7 and HDAC9, which contain serine
at this position, were phosphorylated by recombinant PRK, while
HDAC4, which harbors a non-phosphorylatable alanine residue at
this site, was not phosphorylated by PRK (Fig. 4E).
3.4. Effect of the novel phospho-acceptor site on nuclear import of
MITR
In light of the fact that the novel phospho-acceptor lies within
the conserved class IIa HDAC NLS, studies were performed to ad-
dress the possible role of this site in the control of HDAC subcellu-
lar localization. Given the high degree of phosphorylation of the
HDAC9 substrate (Fig. 4E), and to speciﬁcally evaluate effects on
nuclear import, experiments focused on a splice variant of HDAC9,
termed MITR. As depicted in Fig. 5A, MITR contains an NLS and is
bound by 14-3-3 upon phosphorylation by CaMKI, but lacks an
NES and is thus primarily localized to nuclei. Consistent with our
prior ﬁndings, MITR was found in discrete nuclear structures in
transfected COS cells and becamemore diffusely distributed within
the nucleus in the presence of activated CaMKI (Fig. 5B, column 1).
The nuclear redistribution of MITR is mediated by CaMKI-depen-
dent phosphorylation of the two 14-3-3 target sites in MITR (Ser-
218 and Ser-448) [19].
Aspartic acid was substituted for Ser-253 (analogous to Thr-292
in HDAC5) in order to mimic phosphorylation of the novel site in
the MITR NLS. Like wild-type MITR, the resultant mutant (MITR
[S253D]) was also localized to discrete foci in transfected COS cells,
indicating that the substitution did not affect basal nuclear import
of the protein. Strikingly, however, in the presence of activated
CaMKI, MITR (S253D) dramatically relocalized to the cytoplasm
(Fig. 5B, column 2). In contrast, the localization pattern of a mutant
of containing alanine at this site was identical to that of wild-type
MITR (Fig. 5B, column 3). These results suggest that 14-3-3 bindingcells were transfected with empty expression construct (lane 1; Mock) or vectors for
KC theta (lane 5). Forty-eight hours post-transfection, cell lysates were prepared and
ed by SDS–PAGE, stained with Coomassie blue dye, and 32P-labeled GST-HDAC5 was
d by the Coomassie-stained GST-HDAC5 (lower panel). (B) Lysates from COS cells
e 2) or GST-HDAC5 substrate containing alanine in place of the 14-3-3 target site at
Fig. 3. Mapping the PRK target site on HDAC5. (A) Schematic depiction of GST-HDAC5 substrates and summary of results from (B) and (C). +, phosphorylated; , no detectable
phosphorylation. (B and C) the indicated substrates were used in kinase assays with PRK2 overexpressed in COS cells. Proteins were resolved by SDS-PAGE, stained with
Coomassie blue dye, and 32P-labeled GST-HDAC5 was detected by autoradiography (top panel). Equivalent substrate input was demonstrated by the Coomassie-stained GST-
HDAC5 (lower panel).
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253 in the NLS results in redistribution of the protein to the cyto-
plasm. To further address this possibility, we determined the effect
of ablating one of the 14-3-3-binding sites (Ser-448) on localiza-
tion of the MITR (S253D). As shown in Fig. 5B (column 4), the
resultant protein, MITR (S253D/S448A), was resistant to
CaMKI-mediated cytoplasmic relocalization. Identical results were
obtained when the 14-3-3 site at position 218 was replaced with
alanine (data not shown).
The nuclear export inhibitor, LMB, was used to determine
whether MITR (T253D) exhibits impaired nuclear import or
enhanced nuclear export. As shown in Fig. 5C (upper row), LMB
treatment failed to block CaMKI-mediated localization of MITR
(S253D) in the cytoplasm. The ability of LMB to inhibit CaMKI-
mediated nuclear export of HDAC5 conﬁrmed the integrity of the
LMB preparation (Fig. 5C, lower row). These results suggest that
phosphorylation of the NLS in combination with 14-3-3 binding
to ﬂanking sites impairs nuclear import of MITR.4. Discussion
We provide evidence for a previously unrecognized regulatory
site present in the NLSs of class IIa HDACs-5, -7 and -9. Since the
other class IIa HDAC, HDAC4, lacks the analogous site, this phos-pho-acceptor may provide a mechanism for differential regulation
of class IIa HDACs, and thus class IIa HDAC target genes.
There are three PRK family members, PRK1, PRK2 and PRK3,
which are sometimes referred to as PKNa, PKNb and PKNc, respec-
tively [20]. PRK enzymes bind to and are activated by the Rho GTP-
ases [21–23]. We show that PRK1 and PRK2 are capable of
phosphorylating HDACs-5, -7 and -9, raising the possibility that
Rho GTPases affect gene expression, in part, by stimulating PRK
signaling to class IIa HDACs. The prototypical manner by which
class IIa HDACs repress gene transcription is through association
with myocyte enhancer factor-2 (MEF2), a sequence-speciﬁc DNA
binding transcription factor that regulates genes involved in mus-
cle differentiation and growth. In this regard, STARS, an upstream
activator of Rho, has been shown to potently stimulate MEF2 tran-
scriptional activity in cardiac myocytes [24]. In addition, ectopic
overexpression of activated PRK in smooth muscle cells leads to di-
rect induction of a MEF2 reporter gene [25]. Our results suggest
that PRK signaling to class IIa HDAC could, in part, account for
these previously described effects of the Rho-PRK pathway on
MEF2 activity in muscle.
MITR, which lacks an NES, is predominantly nuclear in most cell
types. However, in C2 myoblasts, where MITR blocks muscle differ-
entiation, small amounts of cytoplasmic MITR can be detected
[15,19]. Additionally, in cerebellar granule neurons cultured in
membrane depolarizing conditions, MITR is found in both the
Fig. 4. Phosphorylation of HDAC peptide substrates by PRK. (A) Alignment of class IIa HDAC amino acid sequences within the region of PRK-directed phosphorylation.
Conserved, putative phospho-acceptor sites are shaded and indicated with and arrow. Increasing amounts of a peptide substrate based on amino acids 283–296 of human
HDAC5 was used for in vitro kinase assays with recombinant PRK1 (B) or PRK2 (C) and c-32P-ATP, as described in the Section 2. Graphs depict 32P-labeling of the peptide in
counts per minute (cpm). (D) Peptide substrates (50 lM) based on wild-type HDAC5 amino acids 283–296 (WT; RRKDGTVISTFKKR) or the equivalent region of HDAC5 but
containing alanine substitutions in place of serine 291 (S291A; RRKDGTVIATFKKR), threonine 292 (T292A; RRKDGTVISAFKKR) or both serine 291 and threonine 292 (S291A/
T292A; RRKDGTVIAAFKKR) were incorporated into in vitro kinase assays with recombinant PRK1 and [c-32P-ATP], as described in the Section 2. Graphs depict 32P-labeling of
the peptides in counts per minute (cpm). (E) In vitro kinase assays were performed as described in (D) with WT HDAC5 peptide or equivalent peptides from HDAC4
(RRKDGPVVTALKKR), HDAC7 (RKESAPPSLRRR) or HDAC9 (RRKDGNVVTSFKKR) and recombinant PRK1. Values represent averages from three independent reactions /+
standard deviation. Statistical signiﬁcance was assessed using one-way ANOVA with Newman–Keuls post-test.
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MITR in these cells is dependent on CaMK signaling [26]. Thus,
phosphorylation of the MITR NLS could contribute to NES-indepen-
dent cytoplasmic localization of the protein in muscle cells and
neurons.
In addition to derepressing nuclear genes, PRK-mediated
redistribution of class IIa HDACs could have effects on extranuclear
protein function. Indeed, acetylation/deacetylation has emerged as
a major mechanism for regulating both nuclear and non-nuclear
proteins, and the scale of this post-translational mechanism was
recently put into perspective by a study deﬁning acetylation siteson of over 1700 distinct proteins from diverse subcellular
compartments [27]. MITR lacks a deacetylase catalytic domain,
and HDACs-5 and -7 possess little to no intrinsic catalytic activity
[28]. However, since these class IIa HDACs form stable complexes
with class I HDACs [28], it remains possible that PRK signaling
could impact the acetylation state of non-nuclear proteins via sig-
naling to class IIa HDACs.
Our studies suggest that cytoplasmic sequestration of MITR is
dependent on both phosphorylation of the NLS and binding of
14-3-3 to serine residues that ﬂank the NLS. It has been suggested
by others that 14-3-3 binding masks the NLS in class IIa HDACs
Fig. 5. A phospho-mimetic impairs nuclear import of MITR. (A) Schematic representations of HDAC5 and MITR. MITR is phosphorylated and bound by 14-3-3, but lacks an
NES. The PRK target sites in the NLSs of HDAC5 and MITR are shown. (B) COS cells were transiently transfected with expression vectors (0.2 lg) encoding GFP-tagged MITR, or
GFP-tagged MITR containing aspartic acid in place of serine 253 (S253D), alanine in place of serine 253 (S253A), aspartic acid for serine 253 and alanine in place of the 14-3-3
target site, serine 448 (S253D/S448A), or alanine for serine 448 alone (S448A). In some cases, cells were co-transfected with a vector encoding constitutively active CaMKI
(0.8 lg; lower panels). Fluorescence images were captured 24 h post-transfection. (C) COS cells were transfected with a vectors (0.2 lg) encoding GFP-MITR (S253D) or GFP-
HDAC5 in the absence (control) or presence of a vector for active CaMKI (0.8 lg). Twenty four hours post-transfection, cells were exposed to the nuclear export inhibitor,
leptomycin B (LMB; 20 nM), for 2 h prior to image capture.
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tered the nuclear distribution of MITR, but did not relocalize the
transcriptional repressor to the cytoplasm. The data suggest a
cooperative mechanism for regulation of MITR nuclear import that
is dependent on the collective phosphorylation of the 14-3-3 sites
and the NLS. Together, these phospho- marks appear to maximally
impair NLS function. Dyrk1B, also known as minibrain-related ki-
nase, has been shown to hinder nuclear import of MITR by phos-phorylating a serine residue that is amino-terminal to Ser-253 in
the NLS [15], suggesting the potential for interplay PRK and Dyrk1B
in the regulation of MITR.
In summary, the studies described here reveal an additional
mechanism for regulating HDACs by impairing nuclear import
of the transcriptional repressors. Since HDACs-5, -7 and -9
contains the PRK target site, while HDAC4 does not, this
mechanism may provide a means for differential regulation of
1110 B.C. Harrison et al. / FEBS Letters 584 (2010) 1103–1110class IIa HDACs and their downstream target genes. Future
studies will need to determine in which cell types and under
what conditions class IIa HDAC NLSs are phosphorylated,
and whether PRK1 and PRK2 are the physiologically relevant
kinases.
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